[
  {
    "title": "Eli Lilly Alzheimer\u2019s therapy set for June FDA AdCom meeting",
    "published": 1715071260,
    "day_prices": {
      "2024-05-07T13:30:00+00:00": 221.97999572753906,
      "2024-05-07T14:30:00+00:00": 219.61000061035156,
      "2024-05-07T15:30:00+00:00": 216.57000732421875,
      "2024-05-07T16:30:00+00:00": 217.2899932861328,
      "2024-05-07T17:30:00+00:00": 217.61000061035156,
      "2024-05-07T18:30:00+00:00": 218.27499389648438,
      "2024-05-07T19:30:00+00:00": 218.83999633789062
    },
    "sentiment": 0.9474264979362488
  },
  {
    "title": "Morgan Stanley\u2019s Top 15 Stock Picks for 2024",
    "published": 1714832848,
    "day_prices": {},
    "sentiment": 0.9358375072479248
  },
  {
    "title": "Biogen price target raised by $3 at HSBC, here's why",
    "published": 1714720140,
    "day_prices": {
      "2024-05-03T13:30:00+00:00": 215.3000030517578,
      "2024-05-03T14:30:00+00:00": 214.3000030517578,
      "2024-05-03T15:30:00+00:00": 214.77000427246094,
      "2024-05-03T16:30:00+00:00": 216.2100067138672,
      "2024-05-03T17:30:00+00:00": 215.3699951171875,
      "2024-05-03T18:30:00+00:00": 216.10499572753906,
      "2024-05-03T19:30:00+00:00": 217.55499267578125
    },
    "sentiment": 0.7540046572685242
  },
  {
    "title": "Biogen Inc. stock underperforms Thursday when compared to competitors",
    "published": 1714622580,
    "day_prices": {
      "2024-05-02T13:30:00+00:00": 217.99000549316406,
      "2024-05-02T14:30:00+00:00": 215.5500030517578,
      "2024-05-02T15:30:00+00:00": 214.80999755859375,
      "2024-05-02T16:30:00+00:00": 215.75999450683594,
      "2024-05-02T17:30:00+00:00": 214.6199951171875,
      "2024-05-02T18:30:00+00:00": 214.27499389648438,
      "2024-05-02T19:30:00+00:00": 214.1199951171875
    },
    "sentiment": 0.9049740433692932
  },
  {
    "title": "AbCellera partners with PE firms to develop antibody drugs, company creation",
    "published": 1714560540,
    "day_prices": {
      "2024-05-01T13:30:00+00:00": 215.55999755859375,
      "2024-05-01T14:30:00+00:00": 215.91000366210938,
      "2024-05-01T15:30:00+00:00": 216.41000366210938,
      "2024-05-01T16:30:00+00:00": 216.88499450683594,
      "2024-05-01T17:30:00+00:00": 215.80999755859375,
      "2024-05-01T18:30:00+00:00": 215.29249572753906,
      "2024-05-01T19:30:00+00:00": 218.02000427246094
    },
    "sentiment": 0.5097097754478455
  },
  {
    "title": "Biogen (BIIB) Partner Begins Filing for Leqembi SC Autoinjector",
    "published": 1715789520,
    "day_prices": {
      "2024-05-15T13:30:00+00:00": 228.97999572753906,
      "2024-05-15T14:30:00+00:00": 231.75999450683594,
      "2024-05-15T15:30:00+00:00": 234.25999450683594,
      "2024-05-15T16:30:00+00:00": 234.7100067138672,
      "2024-05-15T17:30:00+00:00": 235.9199981689453,
      "2024-05-15T18:30:00+00:00": 236.58999633789062,
      "2024-05-15T19:30:00+00:00": 234.88999938964844
    },
    "sentiment": 0.887531042098999
  },
  {
    "title": "Eisai sets new revenue target for Alzheimer\u2019s drug Leqembi",
    "published": 1715775900,
    "day_prices": {
      "2024-05-15T13:30:00+00:00": 228.97999572753906,
      "2024-05-15T14:30:00+00:00": 231.75999450683594,
      "2024-05-15T15:30:00+00:00": 234.25999450683594,
      "2024-05-15T16:30:00+00:00": 234.7100067138672,
      "2024-05-15T17:30:00+00:00": 235.9199981689453,
      "2024-05-15T18:30:00+00:00": 236.58999633789062,
      "2024-05-15T19:30:00+00:00": 234.88999938964844
    },
    "sentiment": 0.5616592764854431
  },
  {
    "title": "Analysts Are Bullish on These Healthcare Stocks: scPharmaceuticals (SCPH), Optinose (OPTN)",
    "published": 1715760120,
    "day_prices": {
      "2024-05-15T13:30:00+00:00": 228.97999572753906,
      "2024-05-15T14:30:00+00:00": 231.75999450683594,
      "2024-05-15T15:30:00+00:00": 234.25999450683594,
      "2024-05-15T16:30:00+00:00": 234.7100067138672,
      "2024-05-15T17:30:00+00:00": 235.9199981689453,
      "2024-05-15T18:30:00+00:00": 236.58999633789062,
      "2024-05-15T19:30:00+00:00": 234.88999938964844
    },
    "sentiment": 0.47826024889945984
  },
  {
    "title": "Biogen partner Eisai begins FDA submissions for injectable Alzheimer\u2019s therapy",
    "published": 1715755620,
    "day_prices": {
      "2024-05-15T13:30:00+00:00": 228.97999572753906,
      "2024-05-15T14:30:00+00:00": 231.75999450683594,
      "2024-05-15T15:30:00+00:00": 234.25999450683594,
      "2024-05-15T16:30:00+00:00": 234.7100067138672,
      "2024-05-15T17:30:00+00:00": 235.9199981689453,
      "2024-05-15T18:30:00+00:00": 236.58999633789062,
      "2024-05-15T19:30:00+00:00": 234.88999938964844
    },
    "sentiment": 0.7766045928001404
  },
  {
    "title": "UPDATE 1-Eisai starts rolling submission for injectable version of Alzheimer's drug with US FDA",
    "published": 1715746627,
    "day_prices": {
      "2024-05-15T13:30:00+00:00": 228.97999572753906,
      "2024-05-15T14:30:00+00:00": 231.75999450683594,
      "2024-05-15T15:30:00+00:00": 234.25999450683594,
      "2024-05-15T16:30:00+00:00": 234.7100067138672,
      "2024-05-15T17:30:00+00:00": 235.9199981689453,
      "2024-05-15T18:30:00+00:00": 236.58999633789062,
      "2024-05-15T19:30:00+00:00": 234.88999938964844
    },
    "sentiment": 0.7023892998695374
  },
  {
    "title": "Eisai Initiates Rolling Biologics License Application to US FDA for LEQEMBI\u00ae (lecanemab-irmb) for Subcutaneous Maintenance Dosing for the Treatment of Early Alzheimer\u2019s Disease Under the Fast Track Status",
    "published": 1715729580,
    "day_prices": {
      "2024-05-14T13:30:00+00:00": 226.10000610351562,
      "2024-05-14T14:30:00+00:00": 222.5800018310547,
      "2024-05-14T15:30:00+00:00": 222.69000244140625,
      "2024-05-14T16:30:00+00:00": 224.0,
      "2024-05-14T17:30:00+00:00": 224.36000061035156,
      "2024-05-14T18:30:00+00:00": 225.55999755859375,
      "2024-05-14T19:30:00+00:00": 226.19000244140625
    },
    "sentiment": 0.6995294094085693
  },
  {
    "title": "Eisai/Biogen initiate FDA BLA for LEQEMBI",
    "published": 1715669640,
    "day_prices": {
      "2024-05-14T13:30:00+00:00": 226.10000610351562,
      "2024-05-14T14:30:00+00:00": 222.5800018310547,
      "2024-05-14T15:30:00+00:00": 222.69000244140625,
      "2024-05-14T16:30:00+00:00": 224.0,
      "2024-05-14T17:30:00+00:00": 224.36000061035156,
      "2024-05-14T18:30:00+00:00": 225.55999755859375,
      "2024-05-14T19:30:00+00:00": 226.19000244140625
    },
    "sentiment": 0.8543344140052795
  },
  {
    "title": "Jim Cramer Likes Micron And Its CEO, Recommends Buying This Big Bank",
    "published": 1715588220,
    "day_prices": {
      "2024-05-13T13:30:00+00:00": 223.0,
      "2024-05-13T14:30:00+00:00": 222.75999450683594,
      "2024-05-13T15:30:00+00:00": 223.6699981689453,
      "2024-05-13T16:30:00+00:00": 224.22500610351562,
      "2024-05-13T17:30:00+00:00": 224.0850067138672,
      "2024-05-13T18:30:00+00:00": 224.6999969482422,
      "2024-05-13T19:30:00+00:00": 224.24000549316406
    },
    "sentiment": 0.9074742197990417
  },
  {
    "title": "The 3 Most Undervalued Pharma Stocks to Buy in May 2024",
    "published": 1715250600,
    "day_prices": {
      "2024-05-09T13:30:00+00:00": 220.6699981689453,
      "2024-05-09T14:30:00+00:00": 220.92999267578125,
      "2024-05-09T15:30:00+00:00": 220.3800048828125,
      "2024-05-09T16:30:00+00:00": 220.77000427246094,
      "2024-05-09T17:30:00+00:00": 221.8699951171875,
      "2024-05-09T18:30:00+00:00": 221.72999572753906,
      "2024-05-09T19:30:00+00:00": 221.85499572753906
    },
    "sentiment": 0.7523890137672424
  },
  {
    "title": "Kirby McInerney LLP Announces the Filing of a Securities Class Action on Behalf of Biogen Inc. (BIIB) Investors",
    "published": 1716492785,
    "day_prices": {
      "2024-05-23T13:30:00+00:00": 223.85000610351562,
      "2024-05-23T14:30:00+00:00": 218.3800048828125,
      "2024-05-23T15:30:00+00:00": 219.27999877929688,
      "2024-05-23T16:30:00+00:00": 219.7209014892578,
      "2024-05-23T17:30:00+00:00": 219.39999389648438,
      "2024-05-23T18:30:00+00:00": 218.48959350585938,
      "2024-05-23T19:30:00+00:00": 217.9199981689453
    },
    "sentiment": 0.6833759546279907
  },
  {
    "title": "DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Biogen",
    "published": 1716483427,
    "day_prices": {
      "2024-05-23T13:30:00+00:00": 223.85000610351562,
      "2024-05-23T14:30:00+00:00": 218.3800048828125,
      "2024-05-23T15:30:00+00:00": 219.27999877929688,
      "2024-05-23T16:30:00+00:00": 219.7209014892578,
      "2024-05-23T17:30:00+00:00": 219.39999389648438,
      "2024-05-23T18:30:00+00:00": 218.48959350585938,
      "2024-05-23T19:30:00+00:00": 217.9199981689453
    },
    "sentiment": 0.864453911781311
  },
  {
    "title": "Biogen (BIIB) to Buy HI-Bio to Expand Rare Disease Pipeline",
    "published": 1716473160,
    "day_prices": {
      "2024-05-23T13:30:00+00:00": 223.85000610351562,
      "2024-05-23T14:30:00+00:00": 218.3800048828125,
      "2024-05-23T15:30:00+00:00": 219.27999877929688,
      "2024-05-23T16:30:00+00:00": 219.7209014892578,
      "2024-05-23T17:30:00+00:00": 219.39999389648438,
      "2024-05-23T18:30:00+00:00": 218.48959350585938,
      "2024-05-23T19:30:00+00:00": 217.9199981689453
    },
    "sentiment": 0.5496787428855896
  },
  {
    "title": "Biogen Bolsters Late-Stage Pipeline, Expands Immunology Portfolio with Agreement to Acquire Human Immunology Biosciences",
    "published": 1716462453,
    "day_prices": {
      "2024-05-23T13:30:00+00:00": 223.85000610351562,
      "2024-05-23T14:30:00+00:00": 218.3800048828125,
      "2024-05-23T15:30:00+00:00": 219.27999877929688,
      "2024-05-23T16:30:00+00:00": 219.7209014892578,
      "2024-05-23T17:30:00+00:00": 219.39999389648438,
      "2024-05-23T18:30:00+00:00": 218.48959350585938,
      "2024-05-23T19:30:00+00:00": 217.9199981689453
    },
    "sentiment": 0.9284027218818665
  },
  {
    "title": "BIIB INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that Biogen Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit",
    "published": 1716445925,
    "day_prices": {
      "2024-05-23T13:30:00+00:00": 223.85000610351562,
      "2024-05-23T14:30:00+00:00": 218.3800048828125,
      "2024-05-23T15:30:00+00:00": 219.27999877929688,
      "2024-05-23T16:30:00+00:00": 219.7209014892578,
      "2024-05-23T17:30:00+00:00": 219.39999389648438,
      "2024-05-23T18:30:00+00:00": 218.48959350585938,
      "2024-05-23T19:30:00+00:00": 217.9199981689453
    },
    "sentiment": 0.47277310490608215
  },
  {
    "title": "Buy Rating Affirmed for Biogen on Strategic Acquisition and Promising Pipeline",
    "published": 1716444960,
    "day_prices": {
      "2024-05-23T13:30:00+00:00": 223.85000610351562,
      "2024-05-23T14:30:00+00:00": 218.3800048828125,
      "2024-05-23T15:30:00+00:00": 219.27999877929688,
      "2024-05-23T16:30:00+00:00": 219.7209014892578,
      "2024-05-23T17:30:00+00:00": 219.39999389648438,
      "2024-05-23T18:30:00+00:00": 218.48959350585938,
      "2024-05-23T19:30:00+00:00": 217.9199981689453
    },
    "sentiment": 0.9363638162612915
  },
  {
    "title": "Biogen\u2019s Buy Rating Bolstered by Strategic Acquisition and Promising Pipeline Expansion",
    "published": 1716441960,
    "day_prices": {
      "2024-05-23T13:30:00+00:00": 223.85000610351562,
      "2024-05-23T14:30:00+00:00": 218.3800048828125,
      "2024-05-23T15:30:00+00:00": 219.27999877929688,
      "2024-05-23T16:30:00+00:00": 219.7209014892578,
      "2024-05-23T17:30:00+00:00": 219.39999389648438,
      "2024-05-23T18:30:00+00:00": 218.48959350585938,
      "2024-05-23T19:30:00+00:00": 217.9199981689453
    },
    "sentiment": 0.952258825302124
  },
  {
    "title": "Analysts Offer Insights on Healthcare Companies: Walgreens Boots Alliance (WBA) and Biogen (BIIB)",
    "published": 1716433380,
    "day_prices": {
      "2024-05-23T13:30:00+00:00": 223.85000610351562,
      "2024-05-23T14:30:00+00:00": 218.3800048828125,
      "2024-05-23T15:30:00+00:00": 219.27999877929688,
      "2024-05-23T16:30:00+00:00": 219.7209014892578,
      "2024-05-23T17:30:00+00:00": 219.39999389648438,
      "2024-05-23T18:30:00+00:00": 218.48959350585938,
      "2024-05-23T19:30:00+00:00": 217.9199981689453
    },
    "sentiment": 0.9072046279907227
  },
  {
    "title": "Pomerantz Law Firm Announces the Filing of a Class Action Against Biogen Inc. and Certain Officers - BIIB",
    "published": 1716406267,
    "day_prices": {
      "2024-05-22T13:30:00+00:00": 228.0,
      "2024-05-22T14:30:00+00:00": 223.8699951171875,
      "2024-05-22T15:30:00+00:00": 224.42999267578125,
      "2024-05-22T16:30:00+00:00": 225.30999755859375,
      "2024-05-22T17:30:00+00:00": 226.0800018310547,
      "2024-05-22T18:30:00+00:00": 225.89999389648438,
      "2024-05-22T19:30:00+00:00": 225.55999755859375
    },
    "sentiment": 0.5583438873291016
  },
  {
    "title": "NEW YORK MARKET CLOSE: Stocks hit as Fed sees higher for longer rates",
    "published": 1716395100,
    "day_prices": {
      "2024-05-22T13:30:00+00:00": 228.0,
      "2024-05-22T14:30:00+00:00": 223.8699951171875,
      "2024-05-22T15:30:00+00:00": 224.42999267578125,
      "2024-05-22T16:30:00+00:00": 225.30999755859375,
      "2024-05-22T17:30:00+00:00": 226.0800018310547,
      "2024-05-22T18:30:00+00:00": 225.89999389648438,
      "2024-05-22T19:30:00+00:00": 225.55999755859375
    },
    "sentiment": 0.9328128695487976
  },
  {
    "title": "Biogen acquiring HI-Bio in increased immunology focus, says William Blair",
    "published": 1716377460,
    "day_prices": {
      "2024-05-22T13:30:00+00:00": 228.0,
      "2024-05-22T14:30:00+00:00": 223.8699951171875,
      "2024-05-22T15:30:00+00:00": 224.42999267578125,
      "2024-05-22T16:30:00+00:00": 225.30999755859375,
      "2024-05-22T17:30:00+00:00": 226.0800018310547,
      "2024-05-22T18:30:00+00:00": 225.89999389648438,
      "2024-05-22T19:30:00+00:00": 225.55999755859375
    },
    "sentiment": 0.939632773399353
  },
  {
    "title": "Biogen, looking to diversify, acquires immune drugmaker HI-Bio for $1.15B",
    "published": 1716376740,
    "day_prices": {
      "2024-05-22T13:30:00+00:00": 228.0,
      "2024-05-22T14:30:00+00:00": 223.8699951171875,
      "2024-05-22T15:30:00+00:00": 224.42999267578125,
      "2024-05-22T16:30:00+00:00": 225.30999755859375,
      "2024-05-22T17:30:00+00:00": 226.0800018310547,
      "2024-05-22T18:30:00+00:00": 225.89999389648438,
      "2024-05-22T19:30:00+00:00": 225.55999755859375
    },
    "sentiment": 0.815977931022644
  },
  {
    "title": "Biogen acquisition has positive read for IGM Biosciences, says RBC Capital",
    "published": 1716374760,
    "day_prices": {
      "2024-05-22T13:30:00+00:00": 228.0,
      "2024-05-22T14:30:00+00:00": 223.8699951171875,
      "2024-05-22T15:30:00+00:00": 224.42999267578125,
      "2024-05-22T16:30:00+00:00": 225.30999755859375,
      "2024-05-22T17:30:00+00:00": 226.0800018310547,
      "2024-05-22T18:30:00+00:00": 225.89999389648438,
      "2024-05-22T19:30:00+00:00": 225.55999755859375
    },
    "sentiment": 0.94495689868927
  },
  {
    "title": "Deep Dive Into Biogen Stock: Analyst Perspectives (17 Ratings)",
    "published": 1716368520,
    "day_prices": {
      "2024-05-22T13:30:00+00:00": 228.0,
      "2024-05-22T14:30:00+00:00": 223.8699951171875,
      "2024-05-22T15:30:00+00:00": 224.42999267578125,
      "2024-05-22T16:30:00+00:00": 225.30999755859375,
      "2024-05-22T17:30:00+00:00": 226.0800018310547,
      "2024-05-22T18:30:00+00:00": 225.89999389648438,
      "2024-05-22T19:30:00+00:00": 225.55999755859375
    },
    "sentiment": 0.7913380861282349
  },
  {
    "title": "Biogen swoops for Human Immunology Biosciences in USD1.8 billion deal",
    "published": 1716366300,
    "day_prices": {
      "2024-05-22T13:30:00+00:00": 228.0,
      "2024-05-22T14:30:00+00:00": 223.8699951171875,
      "2024-05-22T15:30:00+00:00": 224.42999267578125,
      "2024-05-22T16:30:00+00:00": 225.30999755859375,
      "2024-05-22T17:30:00+00:00": 226.0800018310547,
      "2024-05-22T18:30:00+00:00": 225.89999389648438,
      "2024-05-22T19:30:00+00:00": 225.55999755859375
    },
    "sentiment": 0.5264385938644409
  },
  {
    "title": "Biogen inks $1.8B deal to acquire immune drug developer HI-Bio",
    "published": 1716364080,
    "day_prices": {
      "2024-05-22T13:30:00+00:00": 228.0,
      "2024-05-22T14:30:00+00:00": 223.8699951171875,
      "2024-05-22T15:30:00+00:00": 224.42999267578125,
      "2024-05-22T16:30:00+00:00": 225.30999755859375,
      "2024-05-22T17:30:00+00:00": 226.0800018310547,
      "2024-05-22T18:30:00+00:00": 225.89999389648438,
      "2024-05-22T19:30:00+00:00": 225.55999755859375
    },
    "sentiment": 0.5526329874992371
  },
  {
    "title": "Biogen to acquire privately held Human Immunology Biosciences for $1.15 billion upfront",
    "published": 1716362520,
    "day_prices": {
      "2024-05-22T13:30:00+00:00": 228.0,
      "2024-05-22T14:30:00+00:00": 223.8699951171875,
      "2024-05-22T15:30:00+00:00": 224.42999267578125,
      "2024-05-22T16:30:00+00:00": 225.30999755859375,
      "2024-05-22T17:30:00+00:00": 226.0800018310547,
      "2024-05-22T18:30:00+00:00": 225.89999389648438,
      "2024-05-22T19:30:00+00:00": 225.55999755859375
    },
    "sentiment": 0.9204524755477905
  },
  {
    "title": "Why Biogen Inc. (BIIB) is a Top Momentum Stock for the Long-Term",
    "published": 1716299411,
    "day_prices": {
      "2024-05-21T13:30:00+00:00": 229.2899932861328,
      "2024-05-21T14:30:00+00:00": 227.6199951171875,
      "2024-05-21T15:30:00+00:00": 226.5800018310547,
      "2024-05-21T16:30:00+00:00": 226.83999633789062,
      "2024-05-21T17:30:00+00:00": 226.26499938964844,
      "2024-05-21T18:30:00+00:00": 226.9149932861328,
      "2024-05-21T19:30:00+00:00": 227.44000244140625
    },
    "sentiment": 0.8405464291572571
  },
  {
    "title": "Larimar stock rallies 24% on FDA removal of partial clinical hold",
    "published": 1716182340,
    "day_prices": {
      "2024-05-20T13:30:00+00:00": 230.7100067138672,
      "2024-05-20T14:30:00+00:00": 230.6699981689453,
      "2024-05-20T15:30:00+00:00": 230.14500427246094,
      "2024-05-20T16:30:00+00:00": 231.26499938964844,
      "2024-05-20T17:30:00+00:00": 232.4199981689453,
      "2024-05-20T18:30:00+00:00": 231.05999755859375,
      "2024-05-20T19:30:00+00:00": 231.11000061035156
    },
    "sentiment": 0.8574684858322144
  },
  {
    "title": "Ionis (IONS), Biogen Down on Ending Development of ALS Drug",
    "published": 1715955000,
    "day_prices": {
      "2024-05-17T13:30:00+00:00": 229.02099609375,
      "2024-05-17T14:30:00+00:00": 227.48500061035156,
      "2024-05-17T15:30:00+00:00": 228.66000366210938,
      "2024-05-17T16:30:00+00:00": 230.63999938964844,
      "2024-05-17T17:30:00+00:00": 229.52000427246094,
      "2024-05-17T18:30:00+00:00": 229.49000549316406,
      "2024-05-17T19:30:00+00:00": 229.9550018310547
    },
    "sentiment": 0.9018823504447937
  },
  {
    "title": "Biogen Inc. stock underperforms Friday when compared to competitors despite daily gains",
    "published": 1715918520,
    "day_prices": {
      "2024-05-17T13:30:00+00:00": 229.02099609375,
      "2024-05-17T14:30:00+00:00": 227.48500061035156,
      "2024-05-17T15:30:00+00:00": 228.66000366210938,
      "2024-05-17T16:30:00+00:00": 230.63999938964844,
      "2024-05-17T17:30:00+00:00": 229.52000427246094,
      "2024-05-17T18:30:00+00:00": 229.49000549316406,
      "2024-05-17T19:30:00+00:00": 229.9550018310547
    },
    "sentiment": 0.7750614881515503
  },
  {
    "title": "Biogen to halt development of ALS, Angelman Syndrome drugs",
    "published": 1715869860,
    "day_prices": {
      "2024-05-16T13:30:00+00:00": 231.60000610351562,
      "2024-05-16T14:30:00+00:00": 229.58779907226562,
      "2024-05-16T15:30:00+00:00": 229.13999938964844,
      "2024-05-16T16:30:00+00:00": 230.2100067138672,
      "2024-05-16T17:30:00+00:00": 229.49049377441406,
      "2024-05-16T18:30:00+00:00": 228.83999633789062,
      "2024-05-16T19:30:00+00:00": 229.38999938964844
    },
    "sentiment": 0.6543722152709961
  },
  {
    "title": "Biogen, Ionis shelve ALS drug following study failure",
    "published": 1715861100,
    "day_prices": {
      "2024-05-16T13:30:00+00:00": 231.60000610351562,
      "2024-05-16T14:30:00+00:00": 229.58779907226562,
      "2024-05-16T15:30:00+00:00": 229.13999938964844,
      "2024-05-16T16:30:00+00:00": 230.2100067138672,
      "2024-05-16T17:30:00+00:00": 229.49049377441406,
      "2024-05-16T18:30:00+00:00": 228.83999633789062,
      "2024-05-16T19:30:00+00:00": 229.38999938964844
    },
    "sentiment": 0.8339107036590576
  },
  {
    "title": "Biogen says won't exercise option to license and lead development of BIIB121",
    "published": 1715859480,
    "day_prices": {
      "2024-05-16T13:30:00+00:00": 231.60000610351562,
      "2024-05-16T14:30:00+00:00": 229.58779907226562,
      "2024-05-16T15:30:00+00:00": 229.13999938964844,
      "2024-05-16T16:30:00+00:00": 230.2100067138672,
      "2024-05-16T17:30:00+00:00": 229.49049377441406,
      "2024-05-16T18:30:00+00:00": 228.83999633789062,
      "2024-05-16T19:30:00+00:00": 229.38999938964844
    },
    "sentiment": 0.9310190081596375
  },
  {
    "title": "Biogen and Ionis Announce Topline Phase 1/2 Study Results of Investigational Drug in Amyotrophic Lateral Sclerosis",
    "published": 1715859000,
    "day_prices": {
      "2024-05-16T13:30:00+00:00": 231.60000610351562,
      "2024-05-16T14:30:00+00:00": 229.58779907226562,
      "2024-05-16T15:30:00+00:00": 229.13999938964844,
      "2024-05-16T16:30:00+00:00": 230.2100067138672,
      "2024-05-16T17:30:00+00:00": 229.49049377441406,
      "2024-05-16T18:30:00+00:00": 228.83999633789062,
      "2024-05-16T19:30:00+00:00": 229.38999938964844
    },
    "sentiment": 0.6615080833435059
  },
  {
    "title": "Eisai Initiates Rolling Biologics License Application to US FDA for LEQEMBI for Subcutaneous Maintenance Dosing for the Treatment of Early Alzheimer's Disease Under the Fast Track Status",
    "published": 1715854911,
    "day_prices": {
      "2024-05-16T13:30:00+00:00": 231.60000610351562,
      "2024-05-16T14:30:00+00:00": 229.58779907226562,
      "2024-05-16T15:30:00+00:00": 229.13999938964844,
      "2024-05-16T16:30:00+00:00": 230.2100067138672,
      "2024-05-16T17:30:00+00:00": 229.49049377441406,
      "2024-05-16T18:30:00+00:00": 228.83999633789062,
      "2024-05-16T19:30:00+00:00": 229.38999938964844
    },
    "sentiment": 0.685386598110199
  },
  {
    "title": "Biogen (BIIB) Receives a Buy from Truist Financial",
    "published": 1715841420,
    "day_prices": {
      "2024-05-16T13:30:00+00:00": 231.60000610351562,
      "2024-05-16T14:30:00+00:00": 229.58779907226562,
      "2024-05-16T15:30:00+00:00": 229.13999938964844,
      "2024-05-16T16:30:00+00:00": 230.2100067138672,
      "2024-05-16T17:30:00+00:00": 229.49049377441406,
      "2024-05-16T18:30:00+00:00": 228.83999633789062,
      "2024-05-16T19:30:00+00:00": 229.38999938964844
    },
    "sentiment": 0.5580300092697144
  },
  {
    "title": "Biogen: A Balanced View Amidst Setbacks and Alzheimer\u2019s Drug Potential",
    "published": 1715838960,
    "day_prices": {
      "2024-05-16T13:30:00+00:00": 231.60000610351562,
      "2024-05-16T14:30:00+00:00": 229.58779907226562,
      "2024-05-16T15:30:00+00:00": 229.13999938964844,
      "2024-05-16T16:30:00+00:00": 230.2100067138672,
      "2024-05-16T17:30:00+00:00": 229.49049377441406,
      "2024-05-16T18:30:00+00:00": 228.83999633789062,
      "2024-05-16T19:30:00+00:00": 229.38999938964844
    },
    "sentiment": 0.7848695516586304
  },
  {
    "title": "What You Missed On Wall Street On Thursday",
    "published": 1715829360,
    "day_prices": {
      "2024-05-16T13:30:00+00:00": 231.60000610351562,
      "2024-05-16T14:30:00+00:00": 229.58779907226562,
      "2024-05-16T15:30:00+00:00": 229.13999938964844,
      "2024-05-16T16:30:00+00:00": 230.2100067138672,
      "2024-05-16T17:30:00+00:00": 229.49049377441406,
      "2024-05-16T18:30:00+00:00": 228.83999633789062,
      "2024-05-16T19:30:00+00:00": 229.38999938964844
    },
    "sentiment": 0.9199742078781128
  },
  {
    "title": "Europe Approves Biogen's Tofersen For Adult Patients With Rare Type Of Neurodegenerative Disorder",
    "published": 1717172709,
    "day_prices": {
      "2024-05-31T13:30:00+00:00": 219.22999572753906,
      "2024-05-31T14:30:00+00:00": 224.02999877929688,
      "2024-05-31T15:30:00+00:00": 224.25,
      "2024-05-31T16:30:00+00:00": 224.11000061035156,
      "2024-05-31T17:30:00+00:00": 224.7899932861328,
      "2024-05-31T18:30:00+00:00": 224.24940490722656,
      "2024-05-31T19:30:00+00:00": 224.13999938964844
    },
    "sentiment": 0.6018654704093933
  },
  {
    "title": "Repligen (RGEN) Down 10.9% Since Last Earnings Report: Can It Rebound?",
    "published": 1717169509,
    "day_prices": {
      "2024-05-31T13:30:00+00:00": 219.22999572753906,
      "2024-05-31T14:30:00+00:00": 224.02999877929688,
      "2024-05-31T15:30:00+00:00": 224.25,
      "2024-05-31T16:30:00+00:00": 224.11000061035156,
      "2024-05-31T17:30:00+00:00": 224.7899932861328,
      "2024-05-31T18:30:00+00:00": 224.24940490722656,
      "2024-05-31T19:30:00+00:00": 224.13999938964844
    },
    "sentiment": 0.9710344076156616
  },
  {
    "title": "How To Invest: Using Shorter-Term Moving Averages To Trade Stocks",
    "published": 1717156855,
    "day_prices": {
      "2024-05-31T13:30:00+00:00": 219.22999572753906,
      "2024-05-31T14:30:00+00:00": 224.02999877929688,
      "2024-05-31T15:30:00+00:00": 224.25,
      "2024-05-31T16:30:00+00:00": 224.11000061035156,
      "2024-05-31T17:30:00+00:00": 224.7899932861328,
      "2024-05-31T18:30:00+00:00": 224.24940490722656,
      "2024-05-31T19:30:00+00:00": 224.13999938964844
    },
    "sentiment": 0.9395756125450134
  },
  {
    "title": "Biogen: Brussels grants marketing authorization for Charcot disease",
    "published": 1717149620,
    "day_prices": {
      "2024-05-31T13:30:00+00:00": 219.22999572753906,
      "2024-05-31T14:30:00+00:00": 224.02999877929688,
      "2024-05-31T15:30:00+00:00": 224.25,
      "2024-05-31T16:30:00+00:00": 224.11000061035156,
      "2024-05-31T17:30:00+00:00": 224.7899932861328,
      "2024-05-31T18:30:00+00:00": 224.24940490722656,
      "2024-05-31T19:30:00+00:00": 224.13999938964844
    },
    "sentiment": 0.6856043338775635
  },
  {
    "title": "Biogen Receives European Commission Approval for QALSODY\u00ae\u00a0(tofersen), the First Therapy to Treat a Rare, Genetic Form of ALS",
    "published": 1717102260,
    "day_prices": {
      "2024-05-30T13:30:00+00:00": 214.625,
      "2024-05-30T14:30:00+00:00": 213.74000549316406,
      "2024-05-30T15:30:00+00:00": 215.11500549316406,
      "2024-05-30T16:30:00+00:00": 216.83999633789062,
      "2024-05-30T17:30:00+00:00": 218.65499877929688,
      "2024-05-30T18:30:00+00:00": 218.88999938964844,
      "2024-05-30T19:30:00+00:00": 219.39999389648438
    },
    "sentiment": 0.893140971660614
  },
  {
    "title": "Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Biogen Inc. of Class Action Lawsuit and Upcoming Deadlines - BIIB",
    "published": 1717088469,
    "day_prices": {
      "2024-05-30T13:30:00+00:00": 214.625,
      "2024-05-30T14:30:00+00:00": 213.74000549316406,
      "2024-05-30T15:30:00+00:00": 215.11500549316406,
      "2024-05-30T16:30:00+00:00": 216.83999633789062,
      "2024-05-30T17:30:00+00:00": 218.65499877929688,
      "2024-05-30T18:30:00+00:00": 218.88999938964844,
      "2024-05-30T19:30:00+00:00": 219.39999389648438
    },
    "sentiment": 0.9182083010673523
  },
  {
    "title": "Is Eli Lilly Stock A Buy On A Recent Crohn's Disease-Related Rally?",
    "published": 1717072242,
    "day_prices": {
      "2024-05-30T13:30:00+00:00": 214.625,
      "2024-05-30T14:30:00+00:00": 213.74000549316406,
      "2024-05-30T15:30:00+00:00": 215.11500549316406,
      "2024-05-30T16:30:00+00:00": 216.83999633789062,
      "2024-05-30T17:30:00+00:00": 218.65499877929688,
      "2024-05-30T18:30:00+00:00": 218.88999938964844,
      "2024-05-30T19:30:00+00:00": 219.39999389648438
    },
    "sentiment": 0.769070029258728
  },
  {
    "title": "Analyst Favorites With Strong Buyback Activity: Biogen Ranks As a Top Pick",
    "published": 1717071420,
    "day_prices": {
      "2024-05-30T13:30:00+00:00": 214.625,
      "2024-05-30T14:30:00+00:00": 213.74000549316406,
      "2024-05-30T15:30:00+00:00": 215.11500549316406,
      "2024-05-30T16:30:00+00:00": 216.83999633789062,
      "2024-05-30T17:30:00+00:00": 218.65499877929688,
      "2024-05-30T18:30:00+00:00": 218.88999938964844,
      "2024-05-30T19:30:00+00:00": 219.39999389648438
    },
    "sentiment": 0.9347348809242249
  },
  {
    "title": "Analysts\u2019 Opinions Are Mixed on These Healthcare Stocks: Gilead Sciences (GILD), Biogen (BIIB) and Argenx Se (ARGX)",
    "published": 1717063260,
    "day_prices": {
      "2024-05-30T13:30:00+00:00": 214.625,
      "2024-05-30T14:30:00+00:00": 213.74000549316406,
      "2024-05-30T15:30:00+00:00": 215.11500549316406,
      "2024-05-30T16:30:00+00:00": 216.83999633789062,
      "2024-05-30T17:30:00+00:00": 218.65499877929688,
      "2024-05-30T18:30:00+00:00": 218.88999938964844,
      "2024-05-30T19:30:00+00:00": 219.39999389648438
    },
    "sentiment": 0.7460070848464966
  },
  {
    "title": "BIIB Bronstein, Gewirtz & Grossman LLC Announces that Biogen Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!",
    "published": 1717041668,
    "day_prices": {
      "2024-05-30T13:30:00+00:00": 214.625,
      "2024-05-30T14:30:00+00:00": 213.74000549316406,
      "2024-05-30T15:30:00+00:00": 215.11500549316406,
      "2024-05-30T16:30:00+00:00": 216.83999633789062,
      "2024-05-30T17:30:00+00:00": 218.65499877929688,
      "2024-05-30T18:30:00+00:00": 218.88999938964844,
      "2024-05-30T19:30:00+00:00": 219.39999389648438
    },
    "sentiment": 0.8682867884635925
  },
  {
    "title": "Gain Therapeutics: Phase 1 Readout Awaits For Parkinson's Drug With Great Potential",
    "published": 1717006511,
    "day_prices": {
      "2024-05-29T13:30:00+00:00": 216.11000061035156,
      "2024-05-29T14:30:00+00:00": 211.22999572753906,
      "2024-05-29T15:30:00+00:00": 212.60499572753906,
      "2024-05-29T16:30:00+00:00": 213.44000244140625,
      "2024-05-29T17:30:00+00:00": 214.9149932861328,
      "2024-05-29T18:30:00+00:00": 213.97999572753906,
      "2024-05-29T19:30:00+00:00": 214.9199981689453
    },
    "sentiment": 0.9285709857940674
  },
  {
    "title": "Interim results of IGNAZ trial sheds positive light on felzartamab for IgAN",
    "published": 1716992830,
    "day_prices": {
      "2024-05-29T13:30:00+00:00": 216.11000061035156,
      "2024-05-29T14:30:00+00:00": 211.22999572753906,
      "2024-05-29T15:30:00+00:00": 212.60499572753906,
      "2024-05-29T16:30:00+00:00": 213.44000244140625,
      "2024-05-29T17:30:00+00:00": 214.9149932861328,
      "2024-05-29T18:30:00+00:00": 213.97999572753906,
      "2024-05-29T19:30:00+00:00": 214.9199981689453
    },
    "sentiment": 0.939631998538971
  },
  {
    "title": "Biogen Inc. Investor Notice: Robbins LLP Reminds Stockholders of the Class Action Against BIIB",
    "published": 1716928565,
    "day_prices": {
      "2024-05-28T13:30:00+00:00": 216.0,
      "2024-05-28T14:30:00+00:00": 216.84500122070312,
      "2024-05-28T15:30:00+00:00": 217.35000610351562,
      "2024-05-28T16:30:00+00:00": 217.17999267578125,
      "2024-05-28T17:30:00+00:00": 216.7550048828125,
      "2024-05-28T18:30:00+00:00": 217.3000030517578,
      "2024-05-28T19:30:00+00:00": 217.49000549316406
    },
    "sentiment": 0.8303357362747192
  },
  {
    "title": "Biogen reports Leqembi approved for treatment of Alzheimer's in South Korea",
    "published": 1716877200,
    "day_prices": {
      "2024-05-28T13:30:00+00:00": 216.0,
      "2024-05-28T14:30:00+00:00": 216.84500122070312,
      "2024-05-28T15:30:00+00:00": 217.35000610351562,
      "2024-05-28T16:30:00+00:00": 217.17999267578125,
      "2024-05-28T17:30:00+00:00": 216.7550048828125,
      "2024-05-28T18:30:00+00:00": 217.3000030517578,
      "2024-05-28T19:30:00+00:00": 217.49000549316406
    },
    "sentiment": 0.8884419798851013
  },
  {
    "title": "\"LEQEMBI\" Lecanemab) Approved for the Treatment of Alzheimer's Disease in South Korea",
    "published": 1716870787,
    "day_prices": {
      "2024-05-28T13:30:00+00:00": 216.0,
      "2024-05-28T14:30:00+00:00": 216.84500122070312,
      "2024-05-28T15:30:00+00:00": 217.35000610351562,
      "2024-05-28T16:30:00+00:00": 217.17999267578125,
      "2024-05-28T17:30:00+00:00": 216.7550048828125,
      "2024-05-28T18:30:00+00:00": 217.3000030517578,
      "2024-05-28T19:30:00+00:00": 217.49000549316406
    },
    "sentiment": 0.5820940732955933
  },
  {
    "title": "South Korea\u2019s MFDS approves Eisai-Biogen\u2019s LEQEMBI for Alzheimer\u2019s",
    "published": 1716806102,
    "day_prices": {},
    "sentiment": 0.7195767164230347
  },
  {
    "title": "IN BRIEF: Biogen's Alzheimer's treatment wins South Korean approval",
    "published": 1716776340,
    "day_prices": {},
    "sentiment": 0.9092076420783997
  },
  {
    "title": "Parnassus Value Equity Fund Q1 2024 Investment Commentary",
    "published": 1716701400,
    "day_prices": {},
    "sentiment": 0.9324530959129333
  },
  {
    "title": "Why Is Biogen (BIIB) Up 7.7% Since Last Earnings Report?",
    "published": 1716564665,
    "day_prices": {
      "2024-05-24T13:30:00+00:00": 218.2100067138672,
      "2024-05-24T14:30:00+00:00": 218.72000122070312,
      "2024-05-24T15:30:00+00:00": 218.6199951171875,
      "2024-05-24T16:30:00+00:00": 218.9499969482422,
      "2024-05-24T17:30:00+00:00": 217.88999938964844,
      "2024-05-24T18:30:00+00:00": 217.7100067138672,
      "2024-05-24T19:30:00+00:00": 217.75
    },
    "sentiment": 0.8901647329330444
  },
  {
    "title": "The Zacks Analyst Blog Highlights Biogen, Ionis Pharmaceuticals, GSK, PTC Therapeutics and Larimar Therapeutics",
    "published": 1716557880,
    "day_prices": {
      "2024-05-24T13:30:00+00:00": 218.2100067138672,
      "2024-05-24T14:30:00+00:00": 218.72000122070312,
      "2024-05-24T15:30:00+00:00": 218.6199951171875,
      "2024-05-24T16:30:00+00:00": 218.9499969482422,
      "2024-05-24T17:30:00+00:00": 217.88999938964844,
      "2024-05-24T18:30:00+00:00": 217.7100067138672,
      "2024-05-24T19:30:00+00:00": 217.75
    },
    "sentiment": 0.9402798414230347
  },
  {
    "title": "Strategic Acquisitions and Clinical Catalysts Bolster Biogen\u2019s Buy Rating",
    "published": 1716554940,
    "day_prices": {
      "2024-05-24T13:30:00+00:00": 218.2100067138672,
      "2024-05-24T14:30:00+00:00": 218.72000122070312,
      "2024-05-24T15:30:00+00:00": 218.6199951171875,
      "2024-05-24T16:30:00+00:00": 218.9499969482422,
      "2024-05-24T17:30:00+00:00": 217.88999938964844,
      "2024-05-24T18:30:00+00:00": 217.7100067138672,
      "2024-05-24T19:30:00+00:00": 217.75
    },
    "sentiment": 0.9542121887207031
  }
]